Skip to main content

Table 3 Frequencies of KIR-HLA combinations among individuals with acute ischemic stroke and in subjects without stroke

From: HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke

HLA and KIR interaction Subjects with acute ischemic stroke Subjects without acute ischemic stroke p
2DL2-HLA-C1 (n/%) 25 (21.55) 27 (40.9) 0.007
2DL3-HLA-C1 (n/%) 38 (32.75) 22 (33.3) 0.93
2DS2-HLA-C1 (n/%) 37 (31.89) 23 (34.48) 0.94
2DS2-HLA-C2 (n/%) 29 (25.0) 4 (6.06) 0.001
2DL2-HLA-C2 (n/%) 26 (22.41) 11 (16.67) 0.34
2DS1-HLA-C2 (n/%) 15 (12.93) 5 (7.57) 0.42
2DL1-HLA-C1 (n/%) 16 (13.79) 7 (10.6) 0.52
2DL1-HLA-C2 (n/%) 17 (14.65) 13 (13.79) 0.41
  1. KIR killer cell immunoglobulin-like receptor, HLA human leukocyte antigen